(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Emerging Growth Company |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL) |
Applied Materials, Inc. (Registrant) | ||||||||||||||
Date: | November 17, 2022 | By: | /s/ Teri A. Little | |||||||||||
Teri A. Little | ||||||||||||||
Senior Vice President, Chief Legal Officer and Corporate Secretary |
Change | |||||||||||||||||||||||||||||||||||
Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | Q4 FY2022 vs. Q4 FY2021 | FY2022 vs. FY2021 | ||||||||||||||||||||||||||||||
(In millions, except per share amounts and percentages) | |||||||||||||||||||||||||||||||||||
Net sales | $ | 6,749 | $ | 6,123 | $ | 25,785 | $ | 23,063 | 10% | 12% | |||||||||||||||||||||||||
Gross margin | 45.9 | % | 48.1 | % | 46.5 | % | 47.3 | % | (2.2) points | (0.8) points | |||||||||||||||||||||||||
Operating margin | 29.5 | % | 32.9 | % | 30.2 | % | 29.9 | % | (3.4) points | 0.3 points | |||||||||||||||||||||||||
Net income | $ | 1,591 | $ | 1,712 | $ | 6,525 | $ | 5,888 | (7)% | 11% | |||||||||||||||||||||||||
Diluted earnings per share | $ | 1.85 | $ | 1.89 | $ | 7.44 | $ | 6.40 | (2)% | 16% | |||||||||||||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||||||||||||||
Non-GAAP adjusted gross margin | 46.0 | % | 48.2 | % | 46.6 | % | 47.5 | % | (2.2) points | (0.9) points | |||||||||||||||||||||||||
Non-GAAP adjusted operating margin | 29.8 | % | 33.1 | % | 30.5 | % | 31.7 | % | (3.3) points | (1.2) points | |||||||||||||||||||||||||
Non-GAAP adjusted net income | $ | 1,741 | $ | 1,756 | $ | 6,756 | $ | 6,287 | (1)% | 7% | |||||||||||||||||||||||||
Non-GAAP adjusted diluted EPS | $ | 2.03 | $ | 1.94 | $ | 7.70 | $ | 6.84 | 5% | 13% |
Semiconductor Systems | Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 5,038 | $ | 4,307 | $ | 18,797 | $ | 16,286 | |||||||||||||||
Foundry, logic and other | 71 | % | 63 | % | 66 | % | 60 | % | |||||||||||||||
DRAM | 16 | % | 23 | % | 19 | % | 19 | % | |||||||||||||||
Flash memory | 13 | % | 14 | % | 15 | % | 21 | % | |||||||||||||||
Operating income | $ | 1,849 | $ | 1,723 | $ | 6,969 | $ | 6,311 | |||||||||||||||
Operating margin | 36.7 | % | 40.0 | % | 37.1 | % | 38.8 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,858 | $ | 1,732 | $ | 7,000 | $ | 6,362 | |||||||||||||||
Non-GAAP adjusted operating margin | 36.9 | % | 40.2 | % | 37.2 | % | 39.1 | % |
Applied Global Services | Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 1,420 | $ | 1,369 | $ | 5,543 | $ | 5,013 | |||||||||||||||
Operating income | $ | 402 | $ | 425 | $ | 1,661 | $ | 1,508 | |||||||||||||||
Operating margin | 28.3 | % | 31.0 | % | 30.0 | % | 30.1 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 402 | $ | 425 | $ | 1,661 | $ | 1,517 | |||||||||||||||
Non-GAAP adjusted operating margin | 28.3 | % | 31.0 | % | 30.0 | % | 30.3 | % |
Display and Adjacent Markets | Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | |||||||||||||||||||
(In millions, except percentages) | |||||||||||||||||||||||
Net sales | $ | 251 | $ | 417 | $ | 1,331 | $ | 1,634 | |||||||||||||||
Operating income | $ | 34 | $ | 85 | $ | 260 | $ | 314 | |||||||||||||||
Operating margin | 13.5 | % | 20.4 | % | 19.5 | % | 19.2 | % | |||||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||||||||
Non-GAAP adjusted operating income | $ | 34 | $ | 86 | $ | 263 | $ | 327 | |||||||||||||||
Non-GAAP adjusted operating margin | 13.5 | % | 20.6 | % | 19.8 | % | 20.0 | % |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | October 30, 2022 | October 31, 2021 | October 30, 2022 | October 31, 2021 | |||||||||||||||||||
Net sales | $ | 6,749 | $ | 6,123 | $ | 25,785 | $ | 23,063 | |||||||||||||||
Cost of products sold | 3,648 | 3,178 | 13,792 | 12,149 | |||||||||||||||||||
Gross profit | 3,101 | 2,945 | 11,993 | 10,914 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research, development and engineering | 726 | 622 | 2,771 | 2,485 | |||||||||||||||||||
Marketing and selling | 183 | 155 | 703 | 609 | |||||||||||||||||||
General and administrative | 198 | 155 | 735 | 620 | |||||||||||||||||||
Severance and related charges | — | (1) | (4) | 157 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Total operating expenses | 1,107 | 931 | 4,205 | 4,025 | |||||||||||||||||||
Income from operations | 1,994 | 2,014 | 7,788 | 6,889 | |||||||||||||||||||
Interest expense | 57 | 57 | 228 | 236 | |||||||||||||||||||
Interest and other income, net | 12 | 49 | 39 | 118 | |||||||||||||||||||
Income before income taxes | 1,949 | 2,006 | 7,599 | 6,771 | |||||||||||||||||||
Provision for income taxes | 358 | 294 | 1,074 | 883 | |||||||||||||||||||
Net income | $ | 1,591 | $ | 1,712 | $ | 6,525 | $ | 5,888 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 1.86 | $ | 1.91 | $ | 7.49 | $ | 6.47 | |||||||||||||||
Diluted | $ | 1.85 | $ | 1.89 | $ | 7.44 | $ | 6.40 | |||||||||||||||
Weighted average number of shares: | |||||||||||||||||||||||
Basic | 854 | 898 | 871 | 910 | |||||||||||||||||||
Diluted | 859 | 907 | 877 | 919 |
(In millions) | October 30, 2022 | October 31, 2021 | |||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 1,995 | $ | 4,995 | |||||||
Short-term investments | 586 | 464 | |||||||||
Accounts receivable, net | 6,068 | 4,953 | |||||||||
Inventories | 5,932 | 4,309 | |||||||||
Other current assets | 1,344 | 1,386 | |||||||||
Total current assets | 15,925 | 16,107 | |||||||||
Long-term investments | 1,980 | 2,055 | |||||||||
Property, plant and equipment, net | 2,307 | 1,934 | |||||||||
Goodwill | 3,700 | 3,479 | |||||||||
Purchased technology and other intangible assets, net | 339 | 104 | |||||||||
Deferred income taxes and other assets | 2,475 | 2,146 | |||||||||
Total assets | $ | 26,726 | $ | 25,825 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued expenses | $ | 4,237 | $ | 4,268 | |||||||
Contract liabilities | 3,142 | 2,076 | |||||||||
Total current liabilities | 7,379 | 6,344 | |||||||||
Long-term debt | 5,457 | 5,452 | |||||||||
Income taxes payable | 964 | 1,090 | |||||||||
Other liabilities | 732 | 692 | |||||||||
Total liabilities | 14,532 | 13,578 | |||||||||
Total stockholders’ equity | 12,194 | 12,247 | |||||||||
Total liabilities and stockholders’ equity | $ | 26,726 | $ | 25,825 |
(In millions) | Three Months Ended | Twelve Months Ended | |||||||||||||||||||||
October 30, 2022 | October 31, 2021 | October 30, 2022 | October 31, 2021 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ | 1,591 | $ | 1,712 | $ | 6,525 | $ | 5,888 | |||||||||||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 123 | 105 | 444 | 394 | |||||||||||||||||||
Severance and related charges | — | (1) | (4) | 148 | |||||||||||||||||||
Share-based compensation | 99 | 74 | 413 | 346 | |||||||||||||||||||
Deferred income taxes | (14) | 36 | (223) | 80 | |||||||||||||||||||
Other | 22 | (40) | 36 | (70) | |||||||||||||||||||
Net change in operating assets and liabilities | (964) | (738) | (1,792) | (1,344) | |||||||||||||||||||
Cash provided by operating activities | 857 | 1,148 | 5,399 | 5,442 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Capital expenditures | (223) | (206) | (787) | (668) | |||||||||||||||||||
Cash paid for acquisitions, net of cash acquired | — | — | (441) | (12) | |||||||||||||||||||
Proceeds from sales and maturities of investments | 350 | 447 | 1,363 | 1,471 | |||||||||||||||||||
Purchases of investments | (317) | (828) | (1,492) | (2,007) | |||||||||||||||||||
Cash used in investing activities | (190) | (587) | (1,357) | (1,216) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from common stock issuances | 103 | 89 | 199 | 175 | |||||||||||||||||||
Common stock repurchases | (1,500) | (1,500) | (6,103) | (3,750) | |||||||||||||||||||
Tax withholding payments for vested equity awards | (7) | (7) | (266) | (178) | |||||||||||||||||||
Payments of dividends to stockholders | (223) | (216) | (873) | (838) | |||||||||||||||||||
Cash used in financing activities | (1,627) | (1,634) | (7,043) | (4,591) | |||||||||||||||||||
Decrease in cash, cash equivalents and restricted cash equivalents | (960) | (1,073) | (3,001) | (365) | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 3,060 | 6,174 | 5,101 | 5,466 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 2,100 | $ | 5,101 | $ | 2,100 | $ | 5,101 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ | 1,995 | $ | 4,995 | $ | 1,995 | $ | 4,995 | |||||||||||||||
Restricted cash equivalents included in deferred income taxes and other assets | 105 | 106 | 105 | 106 | |||||||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 2,100 | $ | 5,101 | $ | 2,100 | $ | 5,101 | |||||||||||||||
Supplemental cash flow information: | |||||||||||||||||||||||
Cash payments for income taxes | $ | 246 | $ | 210 | $ | 1,869 | $ | 851 | |||||||||||||||
Cash refunds from income taxes | $ | 23 | $ | 1 | $ | 156 | $ | 27 | |||||||||||||||
Cash payments for interest | $ | 68 | $ | 68 | $ | 205 | $ | 205 |
(In millions) | Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | |||||||||||||||||||
Unallocated net sales | $ | 40 | $ | 30 | $ | 114 | $ | 130 | |||||||||||||||
Unallocated cost of products sold and expenses | (232) | (176) | (807) | (725) | |||||||||||||||||||
Share-based compensation | (99) | (74) | (413) | (346) | |||||||||||||||||||
Severance and related charges | — | 1 | 4 | (149) | |||||||||||||||||||
Deal termination fee | — | — | — | (154) | |||||||||||||||||||
Total | $ | (291) | $ | (219) | $ | (1,102) | $ | (1,244) |
Q4 FY2022 | Q4 FY2021 | FY2022 | FY2021 | ||||||||||||||||||||
Net Sales by Geography (In millions) | |||||||||||||||||||||||
United States | $ | 830 | $ | 673 | $ | 3,104 | $ | 2,038 | |||||||||||||||
% of Total | 12 | % | 11 | % | 12 | % | 9 | % | |||||||||||||||
Europe | $ | 375 | $ | 331 | $ | 1,674 | $ | 1,097 | |||||||||||||||
% of Total | 5 | % | 5 | % | 7 | % | 5 | % | |||||||||||||||
Japan | $ | 606 | $ | 613 | $ | 2,012 | $ | 1,962 | |||||||||||||||
% of Total | 9 | % | 10 | % | 8 | % | 8 | % | |||||||||||||||
Korea | $ | 1,082 | $ | 1,004 | $ | 4,395 | $ | 5,012 | |||||||||||||||
% of Total | 16 | % | 17 | % | 17 | % | 22 | % | |||||||||||||||
Taiwan | $ | 2,068 | $ | 1,240 | $ | 6,262 | $ | 4,742 | |||||||||||||||
% of Total | 31 | % | 20 | % | 24 | % | 20 | % | |||||||||||||||
Southeast Asia | $ | 451 | $ | 205 | $ | 1,084 | $ | 677 | |||||||||||||||
% of Total | 7 | % | 3 | % | 4 | % | 3 | % | |||||||||||||||
China | $ | 1,337 | $ | 2,057 | $ | 7,254 | $ | 7,535 | |||||||||||||||
% of Total | 20 | % | 34 | % | 28 | % | 33 | % | |||||||||||||||
Employees (In thousands) | |||||||||||||||||||||||
Regular Full Time | 33.3 | 27.2 |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | October 30, 2022 | October 31, 2021 | October 30, 2022 | October 31, 2021 | |||||||||||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||||||||||
Reported gross profit - GAAP basis | $ | 3,101 | $ | 2,945 | $ | 11,993 | $ | 10,914 | |||||||||||||||
Certain items associated with acquisitions1 | 6 | 6 | 26 | 27 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||||||||||
Other charges | — | — | — | 2 | |||||||||||||||||||
Non-GAAP adjusted gross profit | $ | 3,107 | $ | 2,951 | $ | 12,019 | $ | 10,955 | |||||||||||||||
Non-GAAP adjusted gross margin | 46.0 | % | 48.2 | % | 46.6 | % | 47.5 | % | |||||||||||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,994 | $ | 2,014 | $ | 7,788 | $ | 6,889 | |||||||||||||||
Certain items associated with acquisitions1 | 10 | 11 | 39 | 47 | |||||||||||||||||||
Acquisition integration and deal costs | 6 | 5 | 38 | 45 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||||||||||
Severance and related charges3 | — | (1) | (4) | 157 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Other charges | — | — | — | 6 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 2,010 | $ | 2,029 | $ | 7,861 | $ | 7,322 | |||||||||||||||
Non-GAAP adjusted operating margin | 29.8 | % | 33.1 | % | 30.5 | % | 31.7 | % | |||||||||||||||
Non-GAAP Adjusted Net Income | |||||||||||||||||||||||
Reported net income - GAAP basis | $ | 1,591 | $ | 1,712 | $ | 6,525 | $ | 5,888 | |||||||||||||||
Certain items associated with acquisitions1 | 10 | 11 | 39 | 47 | |||||||||||||||||||
Acquisition integration and deal costs | 6 | 5 | 34 | 46 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||||||||||
Severance and related charges3 | — | (1) | (4) | 157 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | (2) | (41) | (3) | (43) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | 11 | (11) | (4) | (56) | |||||||||||||||||||
Other charges | — | — | — | 6 | |||||||||||||||||||
Income tax effect of share-based compensation4 | 22 | 12 | — | — | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 132 | 4 | 252 | 64 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (26) | 55 | (80) | 33 | |||||||||||||||||||
Income tax effect of non-GAAP adjustments5 | (3) | 10 | (3) | (33) | |||||||||||||||||||
Non-GAAP adjusted net income | $ | 1,741 | $ | 1,756 | $ | 6,756 | $ | 6,287 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
3 | The severance and related charges primarily related to a one-time voluntary retirement program offered to certain eligible employees. | ||||
4 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. | ||||
5 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. | ||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | October 30, 2022 | October 31, 2021 | October 30, 2022 | October 31, 2021 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 1.85 | $ | 1.89 | $ | 7.44 | $ | 6.40 | |||||||||||||||
Certain items associated with acquisitions | 0.01 | 0.01 | 0.04 | 0.04 | |||||||||||||||||||
Acquisition integration and deal costs | 0.01 | 0.01 | 0.03 | 0.04 | |||||||||||||||||||
Certain incremental expenses related to COVID-19 | — | — | — | 0.02 | |||||||||||||||||||
Severance and related charges | — | — | — | 0.13 | |||||||||||||||||||
Deal termination fee | — | — | — | 0.17 | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | — | (0.03) | — | (0.03) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | 0.01 | (0.01) | (0.01) | (0.05) | |||||||||||||||||||
Other charges | — | — | — | 0.01 | |||||||||||||||||||
Income tax effect of share-based compensation | 0.03 | 0.01 | — | — | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 0.15 | — | 0.29 | 0.07 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (0.03) | 0.06 | (0.09) | 0.04 | |||||||||||||||||||
Non-GAAP adjusted earnings per diluted share | $ | 2.03 | $ | 1.94 | $ | 7.70 | $ | 6.84 | |||||||||||||||
Weighted average number of diluted shares | 859 | 907 | 877 | 919 |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | October 30, 2022 | October 31, 2021 | October 30, 2022 | October 31, 2021 | |||||||||||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,849 | $ | 1,723 | $ | 6,969 | $ | 6,311 | |||||||||||||||
Certain items associated with acquisitions1 | 9 | 9 | 31 | 38 | |||||||||||||||||||
Acquisition integration costs | — | — | — | (2) | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||||||||||
Other charges | — | — | — | 3 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,858 | $ | 1,732 | $ | 7,000 | $ | 6,362 | |||||||||||||||
Non-GAAP adjusted operating margin | 36.9 | % | 40.2 | % | 37.2 | % | 39.1 | % | |||||||||||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 402 | $ | 425 | $ | 1,661 | $ | 1,508 | |||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 8 | |||||||||||||||||||
Other charges | — | — | — | 1 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 402 | $ | 425 | $ | 1,661 | $ | 1,517 | |||||||||||||||
Non-GAAP adjusted operating margin | 28.3 | % | 31.0 | % | 30.0 | % | 30.3 | % | |||||||||||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 34 | $ | 85 | $ | 260 | $ | 314 | |||||||||||||||
Certain items associated with acquisitions1 | — | 1 | 3 | 4 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 1 | |||||||||||||||||||
Severance and related charges3 | — | — | — | 8 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 34 | $ | 86 | $ | 263 | $ | 327 | |||||||||||||||
Non-GAAP adjusted operating margin | 13.5 | % | 20.6 | % | 19.8 | % | 20.0 | % | |||||||||||||||
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
3 | The severance and related charges related to workforce reduction actions globally across the Display and Adjacent Markets business. | ||||
Three Months Ended | |||||
(In millions, except percentages) | October 30, 2022 | ||||
Provision for income taxes - GAAP basis (a) | $ | 358 | |||
Income tax effect of share-based compensation | (22) | ||||
Income tax effects related to intra-entity intangible asset transfers | (132) | ||||
Resolutions of prior years’ income tax filings and other tax items | 26 | ||||
Income tax effect of non-GAAP adjustments | 3 | ||||
Non-GAAP adjusted provision for income taxes (b) | $ | 233 | |||
Income before income taxes - GAAP basis (c) | $ | 1,949 | |||
Certain items associated with acquisitions | 10 | ||||
Acquisition integration and deal costs | 6 | ||||
Realized loss (gain) on strategic investments, net | (2) | ||||
Unrealized loss (gain) on strategic investments, net | 11 | ||||
Non-GAAP adjusted income before income taxes (d) | $ | 1,974 | |||
Effective income tax rate - GAAP basis (a/c) | 18.4 | % | |||
Non-GAAP adjusted effective income tax rate (b/d) | 11.8 | % |